Nick Loizos

Nick Loizos has extensive experience in the pharmaceutical industry. Nick began their career as a Group Leader at Imclone Systems Incorporated in 2000, where they were responsible for leading a team. In 2008, they joined Eli Lilly and Company as a Research Advisor, specializing in Cancer ImmunoBiology and Cancer Cell Signaling. Nick developed biologic drugs for cancer treatments during their tenure there. In 2018, Loizos joined Mesoblast Limited as the Vice President of New Technology Development, where they currently work. The summary showcases their progression in the industry and their expertise in drug development for cancer treatments.

Nick Loizos earned a Bachelor of Science (B.S.) degree from Cornell University from 1982 to 1986. Nick later pursued a Doctor of Philosophy (Ph.D.) in Molecular Biology at Albany Medical College. Additionally, they completed a Postdoctoral Fellowship in Protein Science at The Rockefeller University.